Clinical Trials Sponsored by Michel Giunta

Total 1248 results

Michel Giunta
Bayer

Active, not recruiting

Treat and Extend Analysis Trial With Aflibercept in Wet-AMD

Wet Age-related Macular Degeneration

Canada
Dr. Shawkat Michel

Completed

The Extreme Significance of Bilateral Embolic Retinal Phenomena That Can be Life Saving

Life Threatening Diseases | Embolic Shower

Canada
Bercovy, Michel, M.D.

Completed

Total Knee Replacement With the ROCC Knee

Osteoarthritis | Rheumatoid Arthritis

France
Dr. S.S. Michel Clinic

Completed

Monitoring and Preventing Hydroxychloroquine, Plaquenil, Toxicity.

Hydroxychloroquine Toxicity

Canada
Dr. S.S. Michel Clinic

Completed

New, Previously Unknown, Uses of Optical Coherence Tomography Angiography (OCTA) (OCTA)

Sickle Cell Retinopathy
Cabinet d'ostéopathie Michel Boeuf

Not yet recruiting

Evaluation of Osteopathic Protocol on Rachialgia (PO2)

Spine Injuries and Disorders
Dr. S.S. Michel Clinic

Completed

Vitreo-papillary Traction as an Entity Identified by Optical Coherence Tomography (OCT).

Tomography, Optical Coherence

Canada
Dr. S.S. Michel Clinic

Completed

Pituitary Gland Enlargement Was First Diagnosed by Optical Coherence Tomography (OCT) (OCT)

Diagnoses Disease | Pituitary Mass

Canada
Gunma University

Completed

Effect and Safety of Local Injection of Botulinum Toxin Type B Against Digital Ulcer in Systemic Sclerosis

Systemic Sclerosis Patients With Digital Ulcers

Japan
Genta Incorporated

Unknown

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Breast Neoplasm

United States
Genta Incorporated

Unknown

Study of Tesetaxel in Japanese Patients With Solid Tumors

Advanced Solid Tumors

Japan
Genta Incorporated

Completed

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Normal Renal Function | Mildly Impaired Renal Function | Moderately Impaired Renal Function

United States
Genta Incorporated

Unknown

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Melanoma

United States
Genta Incorporated

Completed

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Genta Incorporated

Completed

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma (AGENDA)

Melanoma

United States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
Genta Incorporated

Withdrawn

This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)

Lymphocytic Leukemia
Genta Incorporated

Completed

A Phase I Study of G3139 Subcutaneous in Solid Tumors

Tumors

United States
Diego Hernan Giunta, MD

Unknown

Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide

Hyponatremia

Argentina
Gunma University

Completed

Treating Depressed Mood With a Smartphone-delivered Positive Word Stimulation for Subthreshold Depression

Subthreshold Depression

Japan
Genta Incorporated

Unknown

A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

Solid Tumor

United States
Genta Incorporated

Completed

Effects of Food on the Pharmacokinetics of Tesetaxel 10 mg Capsules

Solid Tumors

United States
Genta Incorporated

Completed

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

Solid Tumors

United States
Genta Incorporated

Unknown

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Adenocarcinoma of the Stomach | Adenocarcinoma of Esophagogastric Junction

United States, Korea, Republic of
Genta Incorporated

Unknown

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer

Gastric Carcinoma

Korea, Republic of
Genta Incorporated

Completed

A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine

Advanced Melanoma
Genta Incorporated

Unknown

Abraxane and Temodar Plus Genasense in Advanced Melanoma

Melanoma

United States
Genta Incorporated

Completed

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | CLL

United States
Gunma University

Completed

Diagnostic Usefulness of Fluorine-18-α-Methyltyrosine PET in Combination With 18F-FDG in Sarcoidosis Patient

Sarcoidosis

Japan
Clinica Valle Giulia

Unknown

Culture Media and Blastocyst Development

Embryo Development

Italy
Gunma University

Completed

Safety and Efficacy of High-dose Leukocytapheresis Using a Large Filter in Refractory Asthma

Bronchial Asthma

Japan
Pinta Biotherapeutics

Completed

Effects of PINTA 745 in End Stage Renal Disease (ESRD) Patients Who Require Hemodialysis and Have Protein Energy Wasting

End Stage Renal Disease | Kidney Disease | Protein Energy Wasting

United States
Gunma University

Completed

MSG and Gastrointestinal Motility

Gastroesophageal Reflux

Japan
Genta Incorporated

Unknown

Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer (TESEGAST)

Gastric Carcinoma

Taiwan, United States, Germany
Genta Incorporated

Unknown

Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer

Prostate Cancer

United States
Genta Incorporated

Unknown

Tesetaxel for Previously Treated Patients With Bladder Cancer

Carcinoma, Transitional Cell

United States, Italy
Genta Incorporated

Unknown

Tesetaxel Every 3 Weeks vs Weekly vs Capecitabine as 1st-line Therapy for Locally Advanced or Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Non-resectable Breast Cancer

United States
Genta Incorporated

Terminated

Pharmacokinetics of G3139 in Subjects With Advanced Melanoma, Including Those With Normal Hepatic Function and Those With Moderate Hepatic Impairment

Advanced Melanoma and Normal or Impaired | Hepatic Function
Gunma University

Completed

Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer

Carcinoma, Non-Small-Cell Lung
Genta Incorporated

Completed

Phase II Gallium Nitrate in Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma | Refractory Lymphoma | Relapsed Lymphoma | Low-Grade Lymphoma | Intermediate-Grade Lymphoma

United States
Olivier Michel

Recruiting

Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria.

Chronic Urticaria

Belgium
Olivier Michel

Unknown

Development of Predictive Biomarkers for the Diagnosis and Treatment of Asthma and COPD in Vietnam.

Chronic Obstructive Respiratory Diseases

Belgium, Vietnam
Michel Torbey

Completed

Effectiveness, Safety and Ease of Application of Excel Cryo Cooling Collar to Rapidly Reduce Core Brain Temperature (CryoCollar)

Stroke

United States
Michael Schiff, MD
UCB Pharma

Completed

Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

Rheumatoid Arthritis

United States
Giulia Manzini

Recruiting

Diagnostic Role of the "White Test" With Lipidic Solution in the Early Intraoperative Identification of Open Bile Ducts for the Prevention of Bile Leakage After Liver Resection (BiLe -Trial) (BiLe)

Bile Leakage

Switzerland
Abidin, Michael, M.D.

Unknown

Hyoid Suspension to the Mandible for the Treatment of Obstructive Sleep Apnea

Obstructive Sleep Apnea

United States
Michael Garron Hospital

Completed

Preoperative Warming Prevents Postoperative Hypothermia in Laparoscopic Gynecologic Surgery. A Randomized Control Trial

Hypothermia | Body Temperature Changes | Hypothermia Following Anesthesia | Hypothermia, Accidental | Hypothermia Due to Anesthetic

Canada
Goldenhersh, Michael, M.D.

Unknown

Affect of Dose Rate on UVR Induced Skin Erythema

Erythema
Mikel Batllori
Instituto de Salud Carlos III

Completed

Comparison of Three Techniques for Ultrasound-guided Internal Jugular Cannulation (OISO-1)

Ultrasound-guided Internal Jugular Cannulation | Central Venous Access Complications

Spain
Michel Burnier

Completed

Treatment Adhesion in Dialysis Patients Treated With Cinacalcet (MEMS-cinac)

Hyperparathyroidism | Chronic Kidney Disease

Switzerland
Jean Michel Hascoet
Maternite Regionale Universitaire

Completed

Prematurity Related Risks of Cognitive Impairment at School Age (NEORIS)

Complications of Prematurity

France

3

Subscribe